Antiarrhythmic drugs for atrial fibrillation in the outpatient setting

被引:0
作者
Tseng, Andrew S. [1 ]
Desimone, Christopher V. [1 ]
Kowlgi, Gurukripa N. [1 ]
机构
[1] Mayo Clin, Dept Cardiovas Med, Rochester, MN USA
关键词
Atrial fibrillation; Cardiac arrhythmias; Outpatients; DIRECT ORAL ANTICOAGULANTS; HEART-FAILURE; DIGOXIN; DRONEDARONE; CAFFEINE; RISK; METAANALYSIS; ASSOCIATION; ARRHYTHMIAS; DOFETILIDE;
D O I
10.23736/S0026-4806.23.08524-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
With burgeoning evidence for early rhythm control in patients with atrial fibrillation (AF), the management of AF in the outpatient setting has become more challenging. The primary care clinician often serves as the frontline in the pharmacologic management of AF. Because of drug interactions and the risk of proarrhythmia, many clinicians remain hesitant about the initiation and chronic management of antiarrhythmic drug prescriptions. However, with the likely increased use of antiarrhythmics for early rhythm control, understanding and familiarity with these medications have likewise become more important, especially since patients with AF probably have other non-cardiac medical conditions that can impact their antiarrhythmic therapy. In this comprehensive review, we provide informative, high-yield cases and edifying references that will help primary care providers become comfortable handling various clinical scenarios.
引用
收藏
页码:839 / 849
页数:11
相关论文
共 50 条
  • [41] Outpatient Management of Oral Anticoagulation in Atrial Fibrillation
    Manning, Julia A.
    CRITICAL CARE NURSING CLINICS OF NORTH AMERICA, 2013, 25 (04) : 481 - +
  • [42] Left Ventricular Hypertrophy and Antiarrhythmic Drugs in Atrial Fibrillation: Impact on Mortality
    Chung, Roy
    Houghtaling, Penny L.
    Tchou, Michael
    Niebauer, Mark J.
    Lindsay, Bruce D.
    Tchou, Patrick J.
    Chung, Mina K.
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2014, 37 (10): : 1338 - 1348
  • [43] Extensive antiarrhythmic drugs after catheter ablation of persistent atrial fibrillation
    Gu, Jun
    Liu, Xu
    Tan, Hongwei
    Zhou, Li
    Gu, Jianing
    Jiang, Weifeng
    Wang, Yuanlong
    Liu, Yugang
    ACTA CARDIOLOGICA, 2012, 67 (04) : 407 - 414
  • [44] THE INTERACTION OF ANTIARRHYTHMIC DRUGS AND THE ENERGY FOR CARDIOVERSION OF CHRONIC ATRIAL-FIBRILLATION
    GUARNIERI, T
    TOMASELLI, G
    GRIFFITH, LSC
    BRINKER, J
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1991, 14 (06): : 1007 - 1012
  • [45] The use of antiarrhythmic drugs for atrial fibrillation in Finland 2007-2018
    Siponen, Rasmus
    Hartikainen, Juha
    Virrankorpi, Janne
    Lappalainen, Antti
    Teppo, Konsta
    Halminen, Olli
    Aro, Aapo
    Marjamaa, Annukka
    Salmela, Birgitta
    Haukka, Jari
    Putaala, Jukka
    Linna, Miika
    Mustonen, Pirjo
    Airaksinen, Juhani
    Lehto, Mika
    SCANDINAVIAN CARDIOVASCULAR JOURNAL, 2025, 59 (01)
  • [46] Antiarrhythmic therapy in atrial fibrillation
    Saoudi, Nadir
    BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2011, 195 (4-5): : 979 - 985
  • [47] Rhythm Control Strategies and the Role of Antiarrhythmic Drugs in the Management of Atrial Fibrillation: Focus on Clinical Outcomes
    T. Jared Bunch
    Bernard J. Gersh
    Journal of General Internal Medicine, 2011, 26 : 531 - 537
  • [48] Antiarrhythmic therapy in atrial fibrillation
    Ravens, Ursula
    PHARMACOLOGY & THERAPEUTICS, 2010, 128 (01) : 129 - 145
  • [49] Atrial Fibrillation Burden Reduction From Antiarrhythmic Drugs in Patients With Cardiac Implantable Electronic Devices
    Schwartz, Sarah M.
    Peigh, Graham
    Culler, Kasen
    Mathew, Daniel
    Verma, Rhea
    Lemma, Betelehem
    Passman, Rod S.
    CIRCULATION, 2023, 148
  • [50] Systematic electrocardioversion for atrial fibrillation and role of antiarrhythmic drugs: A substudy of the SAFE-T trial
    Singh, Steven N.
    Tang, Charlene
    Reda, Domenic
    Singh, Bramah N.
    HEART RHYTHM, 2009, 6 (02) : 152 - 155